Neurology Alert – April 1, 2006
April 1, 2006
View Issues
-
Pharmacology Watch
Can Calcium and Vitamin D Prevent Hip Fractures?; Treatment of Benign Prostatic Hyperplasia; Treatment of Osteoarthritis of the Knee; Refractory Asthma and TNFConnection?; FDA Actions -
Clinical Briefs in Primary Care supplement
-
Natalizumab in Relapsing Multiple Sclerosis—FDA Panel Recommends Use of Drug with Restrictions
In 2 studies involving more than 2000 relapsing MS patients followed for 2 years, monthly infusions of natalizumab (Tysabri) were shown to be highly effective in reducing disease activity. -
Myelopathy in Copper Deficiency
Spinal cord magnetic resonance imaging (MRI) in patients with copper deficiency myelopathy may show increased T2 signal, most commonly in the dorsal midline cervical and thoracic cord. -
Does Your Cell Phone Give You Headaches? Not Likely
No evidence was found to indicate that people with self-reported sensitivity to mobile phone signals are able to detect such signals or that they react to them with increased symptom severity. -
Tailoring Treatment for Glioblastoma Multiforme
Coexpression of EGFRvIII and PTEN by glioblastoma cells is associated with responsiveness to EGFR kinase inhibitors. -
Stroke vs Stroke Mimics: Diagnosis at the Bedside
This prospective study demonstrates that clinical features such as focal deficits, a clear time of onset, and absence of non-neurological signs distinguish a stroke diagnosis from other diagnoses at the bedside. -
Hashimoto's Encephalopathy—Steroid Responsive Syndrome
Subacute encephalopathy associated with thyroid antibodies and a history of autoimmune thyroid disease may respond dramatically to high-dose corticosteroid therapy.